BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11164185)

  • 1. Predictive laboratory diagnostics in oncology utilizing blood-borne cancer cells--current best practice and unmet needs.
    Brandt BH; Schmidt H; de Angelis G; Zänker KS
    Cancer Lett; 2001 Jan; 162 Suppl():S11-S16. PubMed ID: 11164185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-borne cancer cells--quo vadis?
    Brandt B; Schmitt H; Feldner JC; Lellé RJ; Semjonow A; Beckmann A
    Int J Biol Markers; 2000; 15(1):111-3. PubMed ID: 10763152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical significance of circulating tumor cells in the peripheral blood.
    Elshimali YI; Grody WW
    Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive antibody-based CTCs detection from peripheral blood.
    Shahneh FZ
    Hum Antibodies; 2013; 22(1-2):51-4. PubMed ID: 24284308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of a panel of monoclonal antibodies to enrich circulating breast cancer cells facilitates their detection.
    Hager G; Cacsire-Castillo Tong D; Schiebel I; Rezniczek GA; Watrowski R; Speiser P; Zeillinger R
    Gynecol Oncol; 2005 Aug; 98(2):211-6. PubMed ID: 15967487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.
    Soler A; Cayrefourcq L; Mazel M; Alix-Panabières C
    Methods Mol Biol; 2017; 1634():263-276. PubMed ID: 28819858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular phenotyping of circulating tumour cells in patients with prostate cancer: prediction of distant metastases.
    Giesing M; Driesel G; Molitor D; Suchy B
    BJU Int; 2012 Dec; 110(11 Pt C):E1202-11. PubMed ID: 23046102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells Enriched by the Depletion of Leukocytes with Bi-Antibodies in Non-Small Cell Lung Cancer: Potential Clinical Application.
    Yin J; Wang Y; Yin H; Chen W; Jin G; Ma H; Dai J; Chen J; Jiang Y; Wang H; Liu Z; Hu Z; Shen H
    PLoS One; 2015; 10(8):e0137076. PubMed ID: 26317979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients.
    Schmidt H; De Angelis G; Bettendorf O; Eltze E; Semjonow A; Knichwitz G; Brandt B
    Int J Biol Markers; 2004; 19(2):93-9. PubMed ID: 15255540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of antioxidant gene expression levels in circulating cancer cell clusters for the detection of prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL and disease prognostication after radical prostatectomy.
    Giesing M; Suchy B; Driesel G; Molitor D
    BJU Int; 2010 Apr; 105(7):1000-10. PubMed ID: 19818074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M; Torchio M; Mazzini G
    Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomagnetic enrichment of disseminated epithelial tumor cells from peripheral blood by MACS.
    Martin VM; Siewert C; Scharl A; Harms T; Heinze R; Ohl S; Radbruch A; Miltenyi S; Schmitz J
    Exp Hematol; 1998 Mar; 26(3):252-64. PubMed ID: 9502622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
    Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W;
    BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of the primary tumor have independent prognostic value in early breast cancer.
    Tryfonidis K; Kafousi M; Perraki M; Apostolaki S; Agelaki S; Georgoulias V; Stathopoulos E; Mavroudis D
    Clin Breast Cancer; 2014 Dec; 14(6):442-50. PubMed ID: 24958324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology.
    Baker MK; Mikhitarian K; Osta W; Callahan K; Hoda R; Brescia F; Kneuper-Hall R; Mitas M; Cole DJ; Gillanders WE
    Clin Cancer Res; 2003 Oct; 9(13):4865-71. PubMed ID: 14581359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M; Sandri MT
    Methods; 2010 Apr; 50(4):289-97. PubMed ID: 20116432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.
    Xu L; Mao X; Imrali A; Syed F; Mutsvangwa K; Berney D; Cathcart P; Hines J; Shamash J; Lu YJ
    PLoS One; 2015; 10(9):e0138032. PubMed ID: 26397728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of circulating endothelial cell detection in oncology.
    Kraan J; Sleijfer S; Foekens JA; Gratama JW
    Drug Discov Today; 2012 Jul; 17(13-14):710-7. PubMed ID: 22306349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.